Documente Academic
Documente Profesional
Documente Cultură
J. B.
Age
34 y.o
Height
53
Diagnosis
Sex
Female
Weight
60 kg
Author
M. M. Olmillo
Website
milkv.co.vu
A/N
youre welcome J
DRUG DATA
Generic name:
Ferrous sulfate
CLASSIFICATION
Pharmacologic:
Iron preparation
Trade name/s:
Femiron,
Hemocyte, Ircon
Patients dose:
1tab TID
Therapeutic:
Iron preparation
MECHANISM OF
ACTION
Maximum dose:
350mg/day
Onset:
4 days
Minimum dose:
8mg/day
Availability:
Tablets sulfate,
324, 325mg;
syrup fumarate
150mg; elixir
sulfate,
220mg/5mL,
drops sulfate,
75mg/0,6mL,
125mg/mL; tablet,
chewable
fumarate, 100mg;
suspension
fumarate,
100mg/5mL
Pregnancy Category
Risk: A
Peak:
7-10 days
INDICATIONS
General:
> prevention and
treatment of irondeficiency
anemias
> dietary
supplement for
iron
> unlabeled use:
supplemental use
during epoetin
therapy to ensure
proper
hematologic
response to
epoetin
Duration:
2-4 mo.
Metabolism:
Recycled for use, not
known
Distribution:
crosses placenta,
enters breast milk
Excretion:
unknown
Patients actual
indication:
Ferrous sulfate is
given to the
patient for the
prevention and
treatment of irondeficiency anemia
brought about by
the illness
Route: PO
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
Source: 2011
Lippincotts NDG
CONTRAINDICATI
ON
Contraindicated with
allergy to any ingredient;
sulphite allergy;
hemochromatosis,
hemosiderosis,
haemolytic anemias
Precaution:
Use cautiously with
normal iron balance;
peptic ulcer, regional
enteritis, ulcerative colitis
ADVERSE
EFFECTS
Interactions:
> drug-drug: decreased
nti-infective response to
ciprofloxacin, norfloxacin,
ofloxacin; decreased
absorption with antacids,
cimetidine; decreased
effects of levodopa if
taken with iron;
increased serum iron
levels with
chloramphenicol
> drug-food: decreased
absorption with antacids,
eggs or milk, coffee and
tea; avoid concurrent
administration of any of
these
Source: 2011
Lippincotts NDG
NURSING
RESPONSIBILITIE
S
Before:
> check the doctors order
> assess for allergy to any ingredient,
sulfite; hemochromatosis,
hemosiderosis, haemolytic anemias
> assess for skin lesions, color;
gums, teeth (color); bowel sounds
> monitor blood studies
> confirm that client does have iron
deficiency anemia
During:
> verify patients identity
> administer the right drug in the right
dose and route at the right time
> do not crush, chew or cut tablets
and capsules
> give drug with meals (avoiding milk,
eggs, coffee, and tea)
> administer liquid preparations in
water or juice to mask the taste and
prevent staining of teeth; have patient
drink solution with a straw
> do not take this drug with antacids
nor tetracyclines unless prescribed
After:
> warn patient that stool may be dark
or green
> arrange for periodic monitoring of
Hct and Hgb levels
> keep this drug out of reach of
children (may cause fetal poisoning)
> report severe Gi upset, lethargy,
rapid respirations and constipation
> document and record.
Source: 2011
Lippincotts NDG